Silver nanoparticle impregnated poly (ε-caprolactone) scaffolds: Optimization of antimicrobial and noncytotoxic concentrations

Tissue Engineering - Part A

Volumn 17, Issue 3-4, 2011, Pages 439-449

  Madhavan, Ragaseema V ^a   Rosemary, Mathirappillil J ^b   Nandkumar, Maya A ^a   Krishnan, Kalliyana V ^b   Krishnan, Lissy K ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^b Dental Products Laboratory   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BACTERIA; CELL CULTURE; ENDOTHELIAL CELLS; ETHYLENE; ETHYLENE GLYCOL; FUNCTIONAL POLYMERS; MAMMALS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMERASE CHAIN REACTION; SILVER; SYNTHESIS (CHEMICAL); TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PROPERTY; CAPROLACTONE; CELL ATTACHMENTS; CELL TYPES; CULTURE MEDIUM; DOSE RESPONSE; FUNCTIONAL PROTEINS; GRAM-NEGATIVE BACTERIA; IMPLANT-ASSOCIATED INFECTION; MAMMALIAN CELLS; MICROSCOPIC ANALYSIS; MOLECULAR LEVELS; MRNA EXPRESSION; NANOPARTICLE AGGREGATION; REAL-TIME POLYMERASE CHAIN REACTION; SILVER NANOPARTICLES; VASCULAR TISSUE ENGINEERING; ZONE OF INHIBITIONS;

SCAFFOLDS;

MAMMALIA; NEGIBACTERIA; POSIBACTERIA;

ANTIINFECTIVE AGENT; BIOMATERIAL; METAL NANOPARTICLE; POLYCAPROLACTONE; POLYESTER; SILVER; TISSUE SCAFFOLD;

ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; MATERIALS TESTING; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DOSE-RESPONSE RELATIONSHIP, DRUG; MATERIALS TESTING; METAL NANOPARTICLES; POLYESTERS; SILVER; TISSUE SCAFFOLDS;

EID: 79551551097     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0791     Document Type: Article

References (42)

1. Bergamini, T.M., Bandyk, D.F., Govostis, D., Kaebnick, H.W., and Towne, J.B. Infection of vascular prostheses caused by bacterial biofilms. J Vasc Surg 7, 21, 1988.
2. Huh, J., Chen, J.C., Furman, G.M., Malki, C., King, B., Kafie, F., and Wilson, S. Local treatme nt of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin. Eur J Surg Res 74, 54, 1998.
3. Ney, A.L., Granja, J.A., Schuster, P.A., Tsukayama, D.T., Jacobs, D.M., and Bubrick, M.P. The use of biodegradable amikacin microspheres to prevent vascular graft infection. J Surg Res 57, 698, 1994.
4. Jørgensen, L.G., Sørensen, T.S., and Lorentzen, J.E. Clinical and pharmacokinetic evaluation of gentamycin containing collagen in groin wound infections after vascular reconstruction. Eur J Vasc Surg 5, 87, 1991.
5. Holdsworth, J. Treatment of infective and potentially infective complications of vascular bypass grafting using genta-micin with collagen sponge. Ann R Coll Surg Engl 81, 166, 1999.
6. Fiddian, N.J., Sudlow, R.A., and Browett, J.P. Ruptured femoral vein A complication of the use of gentamycin beads in an infected excision arthroplasty of the hip. J Bone Joint Surg Br 66B, 493, 1984.
7. Benaerts, P.J., Ridler, B.M., Vercaeren, P., Thompson, J.F., and Campbell, W.B. Gentamicin beads in vascular surgery: long-term results of implantation. Cardiovasc Surg (Lond Engl) 7, 447, 1999.
8. Nair, L.S., and Laurencin, C.T. Silver nanoparticles: synthesis and therapeutic applications. J Biomed Nanotechnol 3, 301, 2007.
9. Lok, C.N., Ho, C.M., Chen, R., He, Q.Y., Yu, W.Y., Sun, H., Tam, P.K., Chiu, J.F., and Che, C.M. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 5, 916, 2006.
10. Gogoi, S.K., Gopinath, P., Paul, A., Ramesh, A., Ghosh, S.S., and Chattopadhyay, A. Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 22, 9322, 2006.
11. Kim, J.S., Kuk, E., Yu, K.N., Kim, J.H., Park, S.J., Lee, H.J., Kim, S.H., Park, Y.K., Park, Y.H., Hwang, C.Y., et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 3, 95, 2007.
12. Samuel, U., and Guggenbichler, J.P. Prevention of catheter-related infections: the potential of a new nano-silver impregnated. Catheter Int J Antimicrob Agents 23, S75, 2004.
13. Chen, J., Han, C.M., Lin, X.W., Tang, Z.J., and Su, S.J. Effect of silver nanoparticle dressing on second degree burn wound. Zhonghua Wai Ke Za Zhi 44, 50, 2006.
14. Pal, S., Tak, Y.K., and Song, J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Es-cherichia coli. Appl Environ Microbiol 73, 1712, 2007.
15. Shahverdi, A.R., Fakhimi, A., Shahverdi, H.R., and Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylo-coccus aureus and Escherichia coli. Nanomedicine 3, 168, 2007.
16. Panacek, A., Kvtek, L., Prucek, R., Kolar, M., Vecerova, R., Pizurova, N., Sharma, V.K., Nevecna, T., and Zboril, R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B 110, 16248, 2006.
17. Sun, R.W., Chen, R., Chung, N.P., Ho, C.M., Lin, C.L., and Che, C.M. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun (Camb) (40), 5059, 2005.
18. Kim, J.S., et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 3, 95, 2007.
19. Tian, J., Wong, K.K.Y., Ho, C., Lok, C., Yu, W., Che, C., Chiu, J., and Tam, P.K.H. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2, 129, 2007.
20. Hussain, S.M., Hess, K.L., Gearhart, J.M., Geiss, K.T., and Schlager, J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19, 975, 2005.
21. Pankajakshan, D., Philipose, L.P., Palakkal, M., Krishnan, K., and Krishnan, L.K. Development of a fibrin composite coated poly(e-caprolactone) scaffold for potential vascular tissue engineering applications. J Biomed Mater Res B Appl Biomater 87, 570, 2008.
22. Jaffe, E.A., Nachman, R.L., Becker, C.G., and Minick, C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52, 2745, 1973.
23. Chennazhy, K.P., and Krishnan, L.K. Effect of passage number and matrix characteristics on differentiation of en-dothelial cells cultured for tissue engineering. Biomaterials 26, 5658, 2005.
24. Mermal, L.A., et al. Guidelines for the management of in-travascular catheter-related infections. Clin Infect Dis 32, 1249, 2001.
25. Rosenthal, K. Guarding against vascular site infection. Nurs Manag 37, 54, 2006.
26. Radziuk, D., Skirtach, A., Sukhorukov, G., Shchukin, D., and Mohwald, H. Stabilization of silver nanoparticles by poly-electrolytes and poly (ethyleneglycol). Macromol Rapid Commun 28, 848, 2007.
27. Luo, C., Zhang, Y., Zeng, X., Zeng, Y., and Wang, Y. The role of poly(ethylene glycol) in the formation of silver nano-particles. J Colloid Interface Sci 288, 444, 2005.
28. Mallick, K., Witcomb, M.J., and Scurrell, M.S. Self-assembly of silver nanoparticles: formation of a thin silver film in a polymer matrix. Mater Sci Eng C 26, 87, 2006.
29. Popa, M., Pradell, I., Crespo, D., and Calderón-Moreno, J.M. Stable silver colloidal dispersions using short chain polyethylene glycol. Colloids Surfaces A Physicochem Eng Aspects 303, 184, 2007.
30. Morones, J.R., Elechiguerra, J.L., Camacho, A., Holt, K., Kouri, J.B., Ramirez, J.T., and Yacaman, M.J. The bactericidal effect of silver nanoparticles. Nanotechnology 16, 2346, 2005.
31. Sondi, I., and Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275, 177, 2004.
32. Alt, V., Bechert, T., Steinrü cke, P., Wagener, M., Seidel, P., Dingeldein, E., Domann, E., and Schnettler, R. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 18, 4383, 2004.
33. Chen, W., Liu, Y., Courtney, H.S., Bettenga, M., Agrawal, C.M., Bumgardnerj, D., and Ong, J.L. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 27, 5512, 2006.
34. Balamurugan, A., Balossier, G., Laurent-Maquin, D., Pina, S., Rebelo, A.H.S., Faure, J., and Ferreira, J.M.F. An in vitro biological ant anti-bacterial study on a sol-gel derived silver incorporated bioglass system. Dent Mater 24, 1343, 2008.
35. Furno, F., et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 54, 1019, 2004.
36. Hong, K.H., Park, J.L.Y., Sul, I.H., Youk, J.H., and Kang, T.J. Preparation of antimicrobial poly(vinyl alcohol) nanofibers containing silver nanoparticles. J Polym Sci [B] Polym Phys 44, 2468, 2006.
37. Jain, P., and Pradeep, T. Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotechnol Bioeng 90, 59, 2005.
38. Vik, H., Andersen, K.J., Julshamn, K., and Todnem, K. Neuropathy caused by silver absorption from arthroplasty cement. Lancet 8433, 872, 1985.
39. Wen, H., et al. Observation of growth of human fibroblast on silver nanoparticles. J Phys Conf Ser 61, 445, 2007.
40. Roe, D., Karandikar, B., Bonn-Savage, N., Gibbins, B., and Roullet, J.B. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother 61, 869, 2008.
41. Garza-Ocanas, L., et al. Biodistribution and long term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2, 204, 2010.
42. Sadauskas, E., et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4, 10, 2007.